Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04646395 |
Title | Study of Acalabrutinib and Tafasitamab in MZL Patients |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | International Extranodal Lymphoma Study Group (IELSG) |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | ITA | CHE | AUT |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of Wien | Wien | 1190 | Austria | Details | ||
ASST Spedali Civili di Brescia | Brescia | Italy | Details | |||
Fondazione IRCCS - Istituto Nazionale dei Tumori | Milano | Italy | Details | |||
Fondazione IRCCS Cà Granda-Ospedale Maggiore Policlinico | Milano | Italy | Details | |||
Ospedale Maggiore della Carità | Novara | Italy | Details | |||
AUSL Ravenna U.O. Ematologia | Ravenna | 48121 | Italy | Details | ||
Azienda Ospedaliera - IRCCS - Arcispedale Santa Maria Nuova | Reggio Emilia | Italy | Details | |||
Ospedale di Circolo e Fondazione Macchi - ASST Sette Laghi | Varese | Italy | Details | |||
Oncology Institute of Southern Switzerland | Bellinzona | 6500 | Switzerland | Details |